From Casetext: Smarter Legal Research

In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.

United States District Court, S.D. New York
Dec 13, 2022
22md3043 (DLC) (S.D.N.Y. Dec. 13, 2022)

Opinion

22md3043 (DLC) 22mc3043 (DLC)

12-13-2022

IN RE Acetaminophen - ASD-ADHD Products Liability Litigation


ORDER

DENISE COTE UNITED STATES DISTRICT JUDGE

On November 30, 2022, plaintiffs' Liaison Counsel submitted a proposed common benefit order. Attached is a revision to that proposed order ("Draft CB Fund Order”). It is hereby

ORDERED that plaintiffs' Co-Lead Counsel or their designee shall confer with the proposed Special Master for the Common Benefit Fund regarding the Draft CB Fund Order and provide the Court with any proposed revisions.


Summaries of

In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.

United States District Court, S.D. New York
Dec 13, 2022
22md3043 (DLC) (S.D.N.Y. Dec. 13, 2022)
Case details for

In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.

Case Details

Full title:IN RE Acetaminophen - ASD-ADHD Products Liability Litigation

Court:United States District Court, S.D. New York

Date published: Dec 13, 2022

Citations

22md3043 (DLC) (S.D.N.Y. Dec. 13, 2022)